<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="n95/PMC4890247/results/search/disease/results.xml">
  <result pre="mode of transmission for some human respiratory pathogens, such as" exact="influenza" post="virus, respiratory syncytial virus, and coronavirus is believed to"/>
  <result pre="Airborne transmission is the predominant mode of transmission for Mycobacterium" exact="tuberculosis" post="[ 3, 14] and recent evidence has suggested a"/>
  <result pre="more consistently may provide similar levels of reduction in respiratory" exact="viral disease" post="transmission as N95 respirators. This key gap in knowledge"/>
  <result pre="the workplace. Hypotheses Null Hypothesis: The incidence of laboratory confirmed" exact="influenza" post="(primary), influenza-like illness (ILI), acute respiratory illness (ARI) and"/>
  <result pre="guidelines (N95 respirators). Alternative Hypothesis: The incidence of laboratory confirmed" exact="influenza" post="(primary), influenza-like illness (ILI), acute respiratory illness (ARI) and"/>
  <result pre="different between HCPs who practice the CDCâ€™s 2007 guidelines for" exact="influenza" post="protection (medical masks) versus 2009 guidelines for influenza protection"/>
  <result pre="guidelines for influenza protection (medical masks) versus 2009 guidelines for" exact="influenza" post="protection (N95 respirators). Methods General overview ResPECT is a"/>
  <result pre="will have no differences in outcomes, including (1) laboratory confirmed" exact="influenza" post="or (2) influenza-like illness (ILI), (3) acute respiratory illness"/>
  <result pre="The Primary Outcome Measures will be the incidence of: Laboratory-confirmed" exact="influenza" post="(LCI) A or B infection in participants, defined as"/>
  <result pre="or B infection in participants, defined as a) detection of" exact="influenza" post="virus by reverse-transcription polymerase chain reaction (RT-PCR) in an"/>
  <result pre="swab collected within seven days of symptom onset, or b)" exact="influenza" post="seroconversion defined as at least a 4-fold rise in"/>
  <result pre="a 4-fold rise in hemagglutination inhibition antibody (HAI) titers to" exact="influenza" post="A or B virus from the pre- to post-season"/>
  <result pre="significant rise in pre- and post-season serum antibody titers to" exact="influenza" post="A or B virus. Table 3 Potential influenza like"/>
  <result pre="titers to influenza A or B virus. Table 3 Potential" exact="influenza" post="like illness pathogens Influenza A Influenza B Respiratory syncytial"/>
  <result pre="inhibition (HAI) antibody assays will be performed on serum for" exact="influenza" post="A and B virus strains, dependent on the antigens"/>
  <result pre="serum samples will be incubated with 8 hemagglutinin units of" exact="influenza" post="antigen and a turkey red blood cell suspension. The"/>
  <result pre="arm compliance, attitudes and opinions about infection control, receipt of" exact="influenza" post="vaccination, and infectious exposures within and beyond the workplace."/>
  <result pre="relative risk of 0.75) in the incidence of laboratory confirmed" exact="influenza" post="or laboratory confirmed respiratory illness among participants wearing an"/>
  <result pre="rate and levels of within-cluster correlation. The attack rate laboratory-confirmed" exact="influenza" post="during a single study season is assumed to be"/>
  <result pre="administered a vaccine that is 65 % effective in preventing" exact="influenza" post="infection. Vaccine effectiveness at the higher end of published"/>
  <result pre="effect on the needed sample size of annual variations in" exact="influenza" post="incidence is larger than the expected impact of variation"/>
  <result pre="of 0.75 between N95 and surgical masks at preventing laboratory-confirmed" exact="influenza" post="infection, with a Type-I error rate of 0.05. The"/>
  <result pre="and power calculations for primary and secondary outcome Laboratory confirmed" exact="influenza" post="Laboratory confirmed respiratory illness Annual attack rate, Medical Mask"/>
  <result pre="100 % 0.90 Sensitivity analysis Potential outcome analysis for laboratory-confirmed" exact="influenza" post="Some data on the primary outcome may be missing"/>
  <result pre="study. A two-dimensional grid will be created that varies the" exact="influenza" post="attack rates among participants who withdraw. Withdrawal attack rates"/>
  <result pre="monitoring board; HAI, hemagglutination inhibition antibody; HCP, healthcare personnel; ILI," exact="influenza" post="like illness; LCRI, Laboratory confirmed respiratory illness; MM, medical"/>
  <result pre="164 10.1016/j.ajic.2007.10.007 4. collab: Institute of Medicine Preparing for and" exact="influenza" post="pandemic: personal protective equipment for healthcare workers 2008 Washington"/>
  <result pre="Lui SF Fung H Sung J Risk of transmission of" exact="severe acute respiratory syndrome" post="to household contacts by infected health care workers and"/>
  <result pre="of Catalonia Spain TM. Implication of health care personnel in" exact="measles" post="transmission Hum Vaccin Immunother 2015 11 1 288 92"/>
  <result pre="services in an internal medicine unit due to a nosocomial" exact="influenza" post="outbreak Infect Control Hosp Epidemiol 2002 23 615 9"/>
  <result pre="Maesako Y Nakamura F Ohno H Outbreak of pandemic 2009" exact="influenza" post="A/H1N1 infection in the hematology ward: fatal clinical outcome"/>
  <result pre="J et al. Aerosol transmission is an important mode of" exact="influenza" post="A virus spread Nat Commun 2013 4 1935 10.1038/ncomms2922"/>
  <result pre="Olsen SJ Levy J et al. Modes of transmission of" exact="influenza" post="B virus in households PLoS One 2014 9 9"/>
  <result pre="V et al. Surgical mask vs N95 respirator for preventing" exact="influenza" post="among health care workers: a randomized trial JAMA 2009"/>
  <result pre="protection for healthcare workers in the workplace against novel H1N1" exact="influenza" post="A: a letter report. National Academies Press; 2009, p."/>
  <result pre="LM Cohen HJ et al. Reusability of facemasks during an" exact="influenza" post="pandemic: facing the flu 2006 Washington Institute of Medicine,"/>
  <result pre="the compliance with hospital infection control practices during the 2009" exact="influenza" post="H1N1 pandemic in three countries J Hosp Infect 2012"/>
  <result pre="Protection for healthcare workers in the workplace against novel H1N1" exact="influenza" post="A. In: Liverman CT, Harris TA, Rogers MEB, Shine"/>
  <result pre="Interim recommendations for facemask and respirator use to reduce 2009" exact="influenza" post="A (H1N1) virus transmission. 2009. http://www.cdc.gov/h1n1flu/masks.htm. Accessed 28 Sept"/>
  <result pre="Centers for Disease Control and Prevention. Prevention strategies for seasonal" exact="influenza" post="in healthcare settings, 2013. Available at: http://www.cdc.gov/flu/professionals/infectioncontrol/healthcaresettings.htm. Accessed 28"/>
  <result pre="combined nose-throat swabs with nasopharyngeal aspirates for detection of pandemic" exact="influenza" post="A/H1N1 2009 virus by real-time reverse transcriptase PCR J"/>
  <result pre="of nasopharyngeal aspirate and nasal swab specimens for detection of" exact="influenza" post="BMJ 2001 322 7279 138 10.1136/bmj.322.7279.138 11159569 45. Lambert"/>
  <result pre="Pereira MS Skehel JJ Concepts and procedures for laboratory based" exact="influenza" post="surveillance 1982 Atlanta World Health Organization Collaborating Centers for"/>
 </snippets>
</snippetsTree>
